2004
DOI: 10.1172/jci20449
|View full text |Cite
|
Sign up to set email alerts
|

Deletion of vanilloid receptor 1_expressing primary afferent neurons for pain control

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
239
1

Year Published

2004
2004
2018
2018

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 307 publications
(252 citation statements)
references
References 58 publications
7
239
1
Order By: Relevance
“…Consistent with these considerations, luminal application of capsaicin or capsaicin injection into the gut wall lowers sensory threshold or triggers pain in humans (Drewes et al, 2003;Schmulson et al, 2003;Lee et al, 2004). Interestingly, prolonged administration of red pepper, which contains capsaicin, improved symptoms in patients with functional dyspepsia (Bortolotti et al, 2002), likely because of neurotoxic effects of persistent TRPV1 stimulation that leads to transient analgesia in experimental models of neuropathic or inflammatory pain (Karai et al, 2004).…”
Section: Discussionmentioning
confidence: 89%
“…Consistent with these considerations, luminal application of capsaicin or capsaicin injection into the gut wall lowers sensory threshold or triggers pain in humans (Drewes et al, 2003;Schmulson et al, 2003;Lee et al, 2004). Interestingly, prolonged administration of red pepper, which contains capsaicin, improved symptoms in patients with functional dyspepsia (Bortolotti et al, 2002), likely because of neurotoxic effects of persistent TRPV1 stimulation that leads to transient analgesia in experimental models of neuropathic or inflammatory pain (Karai et al, 2004).…”
Section: Discussionmentioning
confidence: 89%
“…Except for some aspects of heat perception, all other sensory modalities (proprioception, touch, and vibration) were preserved and functional abilities improved. There were no adverse behavioral changes [2].…”
Section: Reducing Cancer Painmentioning
confidence: 87%
“…For instance, TRPV1 null mice show virtually no thermal hyperalgesia during inflammation (7). Furthermore, rapid desensitization of TRPV1-expressing fibers by administration of the potent agonist resiniferatoxin attenuates experimental inflammatory hyperalgesia and neurogenic inflammation as well as naturally occurring cancer pain and debilitating arthritic pain (8).…”
Section: The Trpv1mentioning
confidence: 99%